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Mechanism of action of isothiocyanates. A review
Mecanismo de acción de los isotiocianatos. Una revisión
Luis Federico Molina-Vargas1
ABSTRACT RESUMEN
Isothiocyanates (ITC), originating from the enzymatic degra-
dation of glucosinolates (GSL), which are secondary metabolites 
of Brassicaceae plants, exhibit anticarcinogenic properties due 
to their ability to induce cytoprotective genes. The mechanisms 
of cytotoxic and cytostatic effects of ITC include induction of 
apoptosis, inhibition of cell cycle progression and inhibition of 
angiogenesis. Regulation of apoptosis by ITC is accomplished 
primarily through the mitochondrial release of cytochrome 
c, Bcl-2 family regulation, MAPK signaling and subsequent 
activation of caspases. A significant portion of the chemopre-
ventive effects of ITC may be associated with the inhibition of 
the metabolic activation of carcinogens by cytochrome P450 
(phase I), along with increased induction of phase II detoxify-
ing enzymes.
Los isotiocianatos (ITC) originados a partir de la degradación 
enzimática de los glucosinolatos (GSL), los cuales son me-
tabolitos secundarios de las plantas Brassicaceae, exhiben 
propiedades anticarcinogénicas por sus habilidades de inducir 
genes citoprotectivos. Los mecanismos de efectos citotóxicos 
y citostáticos de los ITC incluyen inducción de apoptosis, 
inhibición de la progresión del ciclo celular e inhibición de 
angiogénesis. La regulación de apoptosis por los ITC se logra 
principalmente a través de la liberación mitocondrial del ci-
tocromo c, regulación de la familia Bcl-2, señalización MAPK 
y subsecuente activación de caspasas. Parte importante de los 
efectos quimiopreventivos de los ITC puede estar asociada con 
la inhibición de la activación metabólica de carcinógenos por 
citocromo P450 (fase I), junto con la mayor inducción de las 
enzimas de detoxificación de la fase II.
Key words: apoptosis, glucosinolates, oxidative stress, 
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Introduction
Cruciferae (Brassicaceae), like other plant families, re-
sponds to stress using metabolic pathways that involve the 
biosynthesis of structurally diverse and numerous second-
ary metabolites such as phytoalexins and phytoanticipins, 
which are crucial to defense mechanisms (Pedras et al., 
2009). Included in this type of secondary metabolites are 
glucosinolates (GSL), which are present in only 15 botani-
cal families of the Capparales order and are very abundant 
in the Brassicaceae family (Al-Gendy et al., 2010). When 
these plants are incorporated into the soil by the technique 
known as “biofumigation”, for soil pathogen control, it 
is regarded as a promising and environmentally friendly 
alternative to chemical fumigation (Galletti et al., 2008). 
The biological approach is based on the release of toxic 
compounds derived from GSL with the destruction of tis-
sue in the presence of water (Brown and Morra, 1997). The 
defense induced by the rupture of the GSL is activated by 
tissue damage and the hydrolysis is initiated by the enzyme 
myrosinase (MYR) (Grubb and Abel, 2006). The glucosin-
olate-myrosinase system (GSL-MYR) has become part of 
an evolved and sophisticated defense mechanism against 
insect herbivores and pathogens (Andersson et al., 2009), 
in which GSL are hydrolyzed in a variety of components 
such as isothiocyanates (ITC), nitrites, thiocyanates, epi-
thionitriles and oxazolidines depending on the conditions 
of pH, metal ions, and other proteinic elements (Vaughn 
and Berhow, 2005).
GLS, as well as their ITC derivatives, may partly explain 
the spicy flavor and characteristic odor of Brassicaceae, 
which are very different from other species of the same 
family (Pasini et al., 2012), and play a significant role in 
the cancer preventive properties offered by these plants 
(Zhang et al., 2005). Some products of GSL degradation, 
such as ITC, exhibit the following properties: anticarcino-
genic (Yan and Chen, 2007), antimutagenic, antioxidants, 
antifungal, antibacterial, bioherbicides, and biopesticides 
(Vig et al., 2009). Sulforaphane and erucin, two natural ITC 
that are very abundant in broccoli and other cruciferous 
vegetables, strongly inhibit quorum sensing and virulence 
in Pseudomonas aeruginosa (Ganin et al., 2013).
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The pesticide effect of ITC is associated with dose (Yuan 
et al., 2008) and the type of ITC, which was corroborated 
by Molina (2008) by inhibiting the mycelial growth of 
Rhizoctonia solani using allyl-ITC (AITC), benzyl-ITC 
(BITC), phenyl-ITC (PITC), phenethyl-ITC (PEITC) and 
methyl-ITC (MITC) in vitro. An inhibitory effect was ob-
served in the development of the mycelium with PEITC 
and BITC for six and 20 d respectively, while for AITC, 
PITC and MITC this effect lasted for one year after ap-
plying the treatments, suggesting that the mechanism of 
action involved is different depending on the type of ITC. 
Since no specific mechanism of action of ITC in R. solani, 
or other pathogens, is known, it is necessary to research 
the associated mechanism of action that has been eluci-
dated in different animal models, which is the purpose of 
this review. ITC are potent chemopreventive agents that 
favorably alter carcinogen metabolism in mammals by 
inhibiting the metabolic activation of carcinogens and/or 
by inducing carcinogen detoxification enzymes (Gross et 
al., 2000). In fact, ITC are usually considered as GLS deg-
radation products more biologically active (Gimsing and 
Kirkegaard, 2006), whose main characteristic is volatility 
(Oliviero et al., 2012).
Carcinogenesis
Carcinogenesis is a molecular process induced by genetic 
and epigenetic changes that interrupts pathways that 
control cell proliferation, apoptosis, differentiation and 
senescence. It is generally divided into the stages of initia-
tion, promotion and progression (Fimognari and Hrelia, 
2007). Initiation is defined as an event that usually results 
from mutagenic DNA damage by physical, chemical or 
viral exposure. Promotion is characterized by transform-
ing an initiated cell to a preneoplastic cell population due 
to epigenetic alterations in cells by chronic exposure to 
tumor promoters such as growth factors, hormones or 
ultraviolet radiation. Progression is regarded as the final 
stage of carcinogenesis, which converts preneoplastic cells 
to an invasive and metastatic cell population (Keum et al., 
2004). The principal carcinogen agents are exogenous or 
metabolically generated by reactive oxygen species (ROS) 
and by electrophilic derivatives of the environment and 
normal oxidative processes in vivo. The increased levels 
of ROS are involved in the initiation and promotion of 
tumors and may ultimately lead to carcinogenesis (Yang 
Liu, 2009).
Chemoprevention is defined as the use of natural or syn-
thetic agents that reverse, inhibit or prevent the develop-
ment of cancer (Fimognari and Hrelia, 2007). Virtually all 
dietary and environmental carcinogens undergo a metabol-
ic process after entering the human body. This enzymatic 
process occurs mainly through oxidation and to a lesser 
extent reduction and hydrolysis, which make chemical mol-
ecules more hydrophilic. This physiological event, called 
phase I metabolism, is mainly catalyzed by cytochrome 
P450 (CYP). Consequently, procarcinogens are usually con-
verted into highly reactive intermediates that can bind to 
critical macromolecules such as DNA, RNA and proteins. 
A second group of enzymes, known as phase II enzymes, 
which can combine intermediate reactives with endogenous 
cofactors, leads to the generation of water-soluble products 
that can be readily excreted in bile or urine (Keum et al., 
2004). Some phytochemicals found in fruits and vegetables 
can inhibit the activation of carcinogens, maintaining the 
balance between phase I enzymes that activate carcinogen-
esis and detoxifying enzymes of phase II, which may play a 
protective role against cell damage with xenobiotic agents 
(Yang Liu, 2009), a class of chemical compounds outside 
the body of living organisms and resistant to environmental 
degradation (Belgiorno et al., 2007).
The enzymes of phase I consist mainly of the superfam-
ily of cytochrome P450 (CYP) and microsomal enzymes. 
Conjugators or metabolizing enzymes of phase II consist of 
several enzyme superfamilies including sulfotransferases 
(SULT) and UDP-glucuronosyltransferases (UGT), DT-
diaphorase or NAD (P) H oxidases: quinone oxidoreductase 
(NQO) or NAD (P) H: menadione reductase (NMO), epox-
ide hydrolase (EPH), glutathione S-transferase (GST) and 
N-acetyltransferases (NAT) (Xu et al., 2005). Induction of 
phase II enzymes, such as GST and quinone reductase (QR), 
generally leads to protection of tissues and cells against 
endogenous and/or exogenous carcinogenic intermediates. 
ARE/EpRE (anti-oxidant response element / electrophile 
responsive element) found in the 5’ region of these phase 
II genes may play an important role in mediating their 
induction by xenobiotics including chemopreventive 
agents (Kong et al. 2001). Both the induction of detoxify-
ing enzymes of phase II (GST and QR) and the elevation 
of glutathione (GSH) are the principal strategies to protect 
cells from a variety of endogenous and exogenous toxic 
compounds such as ROS and some chemical carcinogens 
(Ye and Zhang, 2001). 
GSL and the anticancer effect
Cruciferous consumption is more strongly associated with 
protection against cancer than consumption of vegetables 
in general (Blazevic and Mastelic, 2009). Among the most 
studied bioactive compounds in cruciferous associated with 
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protection against cancer are GSL (Fimognari and Hrelia, 
2007); and their hydrolysis products especially receive a lot 
of attention due to their potential anticarcinogenic effect 
(Van Eylen et al., 2009), considered as very potent induc-
ers of phase II detoxifying enzymes, such as GST, while 
reducing phase I enzymes such as CYP (Zhang et al. 1992; 
Seow et al., 2002). GSH conjugation by GST is an impor-
tant step in the metabolism and subsequent detoxification 
of carcinogens, including metabolizing ITC, hydrolysis 
products of GSL, resulting from the formation of conjugates 
of N-acetylcysteine (Seow et al., 2002).
Effect of ITC 
ITC, phytochemicals with promising cancer preventive 
potential, can have advantages and disadvantages in 
the modulation of cellular oxidative stress. While ITC 
transcriptionally stimulate many antioxidant enzymes 
and non-enzymatic proteins, resulting in greater protec-
tion against oxidative stress, they also directly alkylate 
and reduce thiol cellular groups, damage mitochondria 
and elevate ROS, leading to cellular stress (Zhang et al., 
2005). There is dose dependence in these responses: gen-
erally, induction of cytoprotective genes and inhibition 
of CYP activity occur at relatively low concentrations of 
phytochemicals, while activation of cell cycle arrest and 
apoptosis occur at high levels (Hayes et al., 2008). These 
paradoxical effects appear to occur in parallel: the expo-
sure of cells to an ITC quickly leads to a sharp increase in 
stress, which is followed by a delayed but lasting increase 
in cellular protection against oxidants and carcinogens. 
However, while the ITC-induced stress can lead to oxida-
tive damage, it has become increasingly clear that much 
of the chemoprotective activity of ITC is derived from 
the cell response to stress generated by these compounds 
(Zhang et al., 2005).
The mechanisms of cytotoxic and cytostatic effects of ITC 
include induction of apoptosis, inhibition of cell cycle 
progression and inhibition of angiogenesis. The regulation 
of apoptosis by ITC is achieved primarily through mito-
chondrial cytochrome c release, regulation of Bcl-2 family, 
MAPK (mitogen-activated protein kinases) signaling and 
subsequent activation of caspases, a family of cysteine 
proteases responsible for the initiation and execution of 
apoptosis (Traka and Mithen, 2009). The most important 
regulators that have been characterized include caspases 
in apoptosis, the TNF receptor family (Tumor Necrosis 
Factor), adapter proteins and Bcl-2 family, among others 
(Boedefeld et al., 2003).
AITC and PITC are known to inhibit TNF, a protein 
involved in a type of apoptosis known as extrinsic apop-
tosis (Thejass and Kuttan, 2007), while BITC and PEITC, 
aromatic ITC more hydrophobic than AITC (Tang and 
Zhang, 2005), induce a type of apoptosis dependent on 
mitochondrial cytochrome c release (Miyoshi et al., 2004, 
Nakamura et al., 2002) known as intrinsic apoptosis (Shawn 
et al., 2005). PEITC and BITC are more potent inducers of 
apoptosis than AITC and sulforaphane (SFN) (Tang and 
Zhang, 2005).
It appears that a major part of the ITC chemopreven-
tive effects may be associated with the inhibition of the 
metabolic activation of carcinogens by CYP (Phase I), 
together with the strong induction of phase II detoxifying 
enzymes and cellular defensive enzymes. The induction 
of cellular enzymes of phase II are largely mediated by 
ARE (antioxidant responsive element) which is regulated 
by the transcription factor Nrf2 (Keum et al., 2004). The 
enzyme-inducing potential is connected with the total 
intracellular concentrations (Zhang and Talalay, 1998) and 
with the formation of ROS (Nakamura et al., 2000). Since 
GST enzymes metabolize ITC, the beneficial effect of ITC 
is therefore partly dependent on the presence or absence 
of the activity of GST (Seow et al., 2002). Additionally, ITC 
may act as anticarcinogenic agents through more than one 
path. ITC and other inducers of phase II enzymes can act as 
suppressors during the post-initiation of carcinogenesis by 
apoptosis (Bonnesen, et al., 2001; Kirlin et al., 1999). Some 
studies have shown that BITC, for example, may increase 
resistance to apoptosis and promote carcinogenesis when 
administered in the post-initiation phase (Seow et al., 2002).
ITC blocking activity, in particular in SFN, has received 
significant attention, mainly on the induction of phase II 
enzymes via gene expression directed by ARE. Targets di-
rected by ARE include the reductase NAD (P) H: quinone 
(NQO1), heme oxygenase 1 (HO1) and gamma-glutamyl-
cysteine  synthetase (c-GCS), a rate limiting enzyme in the 
synthesis of GSH. The regulation of these genes involved in 
detoxification of carcinogens and oxidants is mediated by 
the nuclear factor Nrf2 (nuclear factor E2-related factor), 
a member of the NF-E2 family which binds to ARE sites 
as a cis activation element in the 5’ region of the genes in 
most phase II enzymes (Clarke et al., 2008). Recent studies 
suggest that Nrf2-mediated signaling, which controls the 
expression of several genes responsible for detoxification 
of carcinogens and protection against oxidative stress, 
is regulated by ITC such as SFN (Yeh and Yen, 2009). 
Transcriptional activation of phase II enzymes is mainly 
mediated by ARE/EpRE (electrophile responsive element) 
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located upstream of the genes involved. Through experi-
ments with EpRE, Ye and Zhang (2001) demonstrated that 
AITC, BITC, PEITC and SFN elevate levels of GST, QR and 
GHS. The correlation between the ITC inducing activity 
and intracellular accumulation levels showed that PEITC 
is accumulated at much lower levels than SFN (ITC con-
trol) and that the accumulated components are also more 
rapidly removed. 
BITC rapidly and continuously accumulates within the 
cells (intracellular concentrations above 300 mM) and 
alters mitochondrial function. The production of ROS and 
the resulting change in the cellular redox potential may be 
part of the signal transduction pathway during apoptosis 
(Miyoshi et al., 2004). ITC enter cells and are converted 
to their respective GST conjugates, which ultimately leads 
to reduced intracellular GSH. Additionally, free ITC also 
react with intracellular proteins with thiocarbamoylation 
reactions. It is believed that reducing cellular GSH and 
protein thiocarbamoylation activate signal transduction 
pathways and apoptotic mechanisms (Satyan et al., 2006). 
ITC accumulate in cells with intracellular levels reaching 
the millimolar range, as dithiocarbamates (DTC) derived 
from intracellular GSH conjugation, which is a determinant 
factor in the accumulation. Inducing activity of almost 
all phase II enzyme inducers are related to their chemi-
cal reactivity with sulfhydryl groups. Both ITC and their 
DTC derivatives may change the reaction with sulfhydryl 
groups (Ye and Zhang, 2001). In vivo, ITC are conjugated 
with GSH and then sequentially metabolized in mercuric 
acid. These metabolites are collectively designated DTC 
(Shapiro et al., 2001).
ITC and oxidative stress
Oxidative stress, the cellular imbalance between the pro-
duction and the elimination of ROS, is thought to be the 
basis of the pathogenesis of various diseases. ITC may act 
indirectly, increasing the antioxidant capacity of animal 
cells by inducing the activity of phase II enzymes or by 
increasing levels of GSH (Traka and Mithen, 2009). BITC 
induces expression of GSTP1 (GST isoenzyme) to medi-
ate intracellular ROI (reactive oxygen intermediates) with 
short periods of time (1 h) that are sufficient to elevate GST 
activity; and ROI production activities are highly correlated 
with the induction of GST, whereas the antioxidant GSH 
inhibits them (Miyoshi et al., 2004). AITC and PITC inhibit 
specific angiogenesis by tumors through the significant re-
duction of the production of nitric oxide (NO) and TNF-α 
(Tumor necrosis factor-α) (Thejass and Kuttan, 2007). ITC, 
upon oxidation, are converted into their corresponding 
isocyanate chromosome aberration causing mutations and 
cancer. These events could be correlated with the potential 
of the ITC with intracellular ROI production, although 
the cytotoxicity of high ITC doses can be inhibited by the 
antioxidant N-acetylcysteine  (Miyoshi et al., 2004).
ITC and apoptosis
Apoptosis or programmed cell death is an active process 
whereby dysfunctional cells are removed to maintain 
normal functioning of the tissues. Depending on the 
stimulus, apoptosis can be initiated by the mitochondrial 
pathway intrinsically or extrinsically, or receptor mediated 
in response to exogenous stimuli. The main executors of 
apoptosis are caspases (cysteine  aspartyl protease) that can 
be subdivided into two groups: initiator caspases which 
initiate apoptosis by activating a second group, downstream 
effectors or executing caspases. Several endogenous inhibi-
tors, including anti-apoptotic members of the Bcl-2 family, 
inhibit the activation of caspases (Shawn et al., 2005). Bcl-2 
is a prototypical antiapoptotic protein, a member of the 
class of molecules classified under the Bcl-2 family, has the 
ability to form heterodimers which constitutes the basis of 
the model that involves the prototypical antiapoptotic Bcl-2 
factor and is the prototypical proapoptotic Bax member. 
Under this model, the cell susceptibility to apoptosis de-
pends on the relative amounts of Bcl-2/Bax heterodimers, 
Bax/Bax homodimers, and Bcl-2/Bcl-2 homodimers. An 
excess of proapoptotic homodimers (Bax) will result in 
apoptosis, while an excess of Bcl-2 homodimers results in 
cell survival. 
Another theory related to the inherent ability of these fam-
ily members to interact involves the creation of a cluster of 
molecules including cytochrome c, caspases and adapter 
proteins. The functions of Bcl-2 include the creation of 
membrane channels, the regulation of caspase activity 
and inhibiting the output of mitochondrial cytochrome c 
(Boedefeld et al., 2003). MAPK, important components of 
cell signaling, converts various extracellular signals into 
intracellular responses through phosphorylation cascades. 
Three different MAP kinase cascades have been identified 
that are parallel and correspond to: ERK (extracellular 
signal-regulated kinases), JNK (c-Jun NH 2-terminal 
kinases) and p38 (Kong et al., 2001; Yeh and Yen, 2009), 
which along with MAPK belong to a superfamily of serine/
threonine kinases, which play a role in carcinogenesis and 
cancer development (Clarke et al., 2008); and which when 
activated can phosphorylate many transcription factors, 
ultimately generating changes in the expression of genes 
(Kong et al., 2001). Given the fact that MAPK are activated 
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by a wide range of factors, these signaling cascades may 
serve as common mechanisms that integrate signaling 
pathways to control cellular responses to various extracel-
lular stimuli, including pharmacological and xenobiotics 
agents (Kong et al., 2001; Yeh and Yen, 2009).
Miyoshi et al. (2004), with experiments using epithelial rat 
liver cells, showed that BITC synergistically modifies the 
antiapoptotic function of Bcl-2 through the phosphoryla-
tion catalyzed by JNK and induces apoptosis dependent 
on mitochondrial death via the activation of caspases 9 
and 3, but they did not observe significant changes in the 
expression or degradation of Bcl-2 and Bax as suggested by 
Chen et al. (1998), who reported the importance of protein 
expression of the Bcl-2 family during apoptosis induced by 
components related to ITC.
Mitochondria are damaged by ITC intracellular metabo-
lites that can accumulate in the cells and mitochondrial 
damage induced by ITC leads to cytochrome c release, 
caspase-9 activation and apoptosis. Similarly, the action 
of ITC in mitochondria involves Bcl-2 family member 
proteins, which influence the integrity of the membrane. 
The ability of AITC, BITC, PEITC and SFN to activate 
caspase 9 is strongly correlated with their ability to cause 
transmembrane potential loss and release of cytochrome 
c, depending on dose and time of exposure (Tang and 
Zhang, 2005). BITC induces cytochrome c release from 
mitochondria (Nakamura et al., 2002), while Bcl-2/Bax 
decreased interaction with BITC treatments. Bcl-2 ap-
pears to lose the ability of phosphorylated binding with 
Bax, generating the enhanced susceptibility of the cells to 
apoptosis. Bcl-2 phosphorylation, induced by BITC, could 
dissociate the interaction between Bcl-2 and Bax, result-
ing in the induction of apoptosis triggered by the signal 
of mitochondrial death (Miyoshi et al., 2004). BITC and 
PEITC stimulate phosphorylation of Bcl-2 at a dose of 7.5 
mmol L-1 but in high concentrations (15-30 mmol L-1) cause 
more damage to the mitochondria (Tang and Zhang, 2005). 
Treatments with excessive BITC concentrations result in 
severe cytotoxicity without the formation of the DNA 
ladder (DNA fragmentation into nucleosome units and 
chromatin condensation are characteristics of apoptosis). 
BITC induces ROS production in a dose dependent man-
ner. These phenomena may lead to oxidative cell death 
by necrosis and therefore damage the cells (Miyoshi et 
al., 2004). PEITC inhibits several CYP enzymes involved 
in the metabolic activation of carcinogens and sensitizes 
cells to apoptosis by sustained activation of JNK and the 
stress-activated protein kinases pathway (Satyan et al., 
2006). The effect in Bak and Bcl-2 is highly dependent on 
the concentration of ITC. ITC can cause dissociation of 
Bcl-XL with Bak and Bax in the mitochondria and cause 
damage. Exposure of cells to ITC, including BITC and 
PEITC, also result in a rapid increase of ROS at the cellular 
level, dose dependent. Mitochondria are the principal sites 
of ROS production, which could result in the breaking of 
the respiratory chain. The aromatic ITC, BITC and PEITC 
are hydrophobic and powerful agents, causing damage in 
mitochondria, whereas AITC and SN are more soluble and 
show less potential for damage to the membrane. The high 
lipid solubility facilitates the release of membrane compo-
nents. Mitochondrial damage is caused by the principal 
intracellular metabolites of ITC (their GSH conjugates). 
The increased phosphorylation of Bcl-2, mitochondrial 
translocation of Bak and disruption of the association of 
Bcl-xL with Bak and Bax in mitochondria occur in ITC 
treatments, which contributes to mitochondrial damage 
and apoptosis (Tang and Zhang, 2005).
ITC and the cell cycle
When DNA is damaged, cell cycle arrest occurs through 
the activation of cellular control points such as the phases 
G1/S or G2/M until the errors are corrected in the DNA. 
However, if DNA damage is enormous and irreparable, 
apoptosis is initiated instead of cell cycle arrest. Thus, both 
cell cycle arrest and apoptosis are closely linked as cellular 
protection mechanisms (Keum et al., 2004). The orderly 
progression of mammalian cell division through phases G1, 
S, G2, and M is governed by a set of proteins called cyclins, 
which exert their effects by binding and activating a series 
of kinases dependent on specific cyclins (CDK, cyclin de-
pendent kinases). This process is modulated by inhibiting 
proteins such as p21/WAF-1, p16/INK41 and p27/Kip-1, 
collectively referred to as CDK inhibitors (Keum et al., 
2004). The ITC ability to regulate the cell cycle and inhibit 
proliferation contributes to the chemopreventive ability 
and is mediated through indirect orientation of molecules 
and CDK inhibitors (Traka and Mithen, 2009). Visanji et 
al. (2004) showed that PEITC and BITC arrest cell cycle in 
the G2 phase of the Caco-2 colon cell, inducing p21waf1/cip1 
expression. The progression through the G1/S checkpoint 
of the cell cycle is regulated by the CDK family, whose 
activity is in turn controlled by CDK inhibitors, including 
p21waf1/cip1 (Bott et al., 2005). The arrest of the G2/M phase by 
BITC in human pancreatic cancer cells are also associated 
with the activation of Chk2 (checkpoint kinase 2), whereas 
expression of other regulatory proteins of the G2/M phase, 
including cyclin B1, Cdc2 (Cell division cycle 2) and 
Cdc25C (cell division cycle 25C) were sub-regulated (Zhang 
et al., 2006). AITC treatments targeted accumulation of 
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prostate cancer cells in the G2/M phase with the down-
regulation of Cdk1 (cyclin dependent kinase 1), Cdc25B 
and Cdc25C proteins (Xiao et al., 2003; Tang et al., 2006). 
SFN caused G2/M phase arrest and increased the fraction 
of apoptotic cells in a time and dose dependent manner, 
with necrosis after prolonged exposure to high doses. 
SFN altered cell cycle progression and induced apoptosis, 
increasing the expression of p53 and Bax and negatively 
affected the expression of Bcl-2 (Fimognari et al., 2002). 
The ITC BITC, PEITC and SFN are electrophiles that bind 
covalently to certain cysteine  residues in tubulin, protein 
constituent of microtubules, inducing changes in the 
formation and collapse of the same, which contribute to 
cell cycle arrest in G2/M and apoptosis (Mi et al., 2009). 
PEITC cells suppressed the proliferation of PC-3 (prostate 
cancer cells) in a dose dependent manner, causing arrest 
in the G2/M phase cell cycle and apoptosis by reducing 
the level of Cdk1 and Cdc25C. Interestingly, PITC, which 
is structurally similar to PEITC, does not have the same 
effects. These results indicate that even a subtle change 
in the structure of the ITC can have a significant impact 
on its biological activity (Xiao et al. 2004).
Conclusions
The fungistatic effect of several ITC in the in vitro assay 
performed by Molina (2008), with differences in inhibition 
of mycelial growth of R. solani, suggests several mecha-
nisms of action dependent on dose and ITC type. While 
the fungistatic effect produced by benzyl-ITC (BITC) and 
phenethyl-ITC (PEITC) lasted 6 and 20 d, respectively, in 
allyl-ITC (AITC), methyl-ITC (MITC) and phenyl-ITC 
(PITC) the inhibitory effect lasted up to one year after the 
treatments were applied. It is evident that the response is 
dose dependent, since, generally, cytoprotective gene induc-
tion and inhibition of CYP activity occur at relatively low 
ITC concentrations, while activation of cell cycle arrest and 
apoptosis occur at high doses.
The mechanisms of cytotoxic and cytostatic ITC effects 
include induction of apoptosis, inhibition of cell cycle 
progression and inhibition of angiogenesis. The regula-
tion of apoptosis by ITC is achieved primarily through 
mitochondrial cytochrome c release, regulation of the 
Bcl-2 family, MAPK signaling and subsequent activation 
of caspases, responsible for the initiation and execution 
of apoptosis. Specifically, AITC and PITC inhibit TNF 
(extrinsic apoptosis), generating a mycelial inhibition 
for several months, while BITC and PEITC induce a cy-
tochrome c release-dependent type of apoptosis from mi-
tochondria (intrinsic apoptosis) that generates a mycelial 
inhibition that lasts only a few days. The differences in 
the fungistatic effect of ITC are possibly due to the type 
of apoptosis induced.
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